GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Common Stock

Oncodesign Precision Medicine (XPAR:ALOPM) Common Stock

: €0.00 Mil (As of Jun. 2022)
View and export this data going back to 2022. Start your Free Trial

Oncodesign Precision Medicine's quarterly common stock stayed the same from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€0.00 Mil) and stayed the same from Dec. 2021 (€0.00 Mil) to Jun. 2022 (€0.00 Mil).

Oncodesign Precision Medicine's annual common stock increased from . 20 (€0.00 Mil) to Dec. 2020 (€0.00 Mil) but then stayed the same from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€0.00 Mil).


Oncodesign Precision Medicine Common Stock Historical Data

The historical data trend for Oncodesign Precision Medicine's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - )
Oncodesign Precision Medicine Annual Data
Trend Dec20 Dec21
Common Stock
- -

Oncodesign Precision Medicine Semi-Annual Data
Dec20 Dec21 Jun22
Common Stock - - -

Oncodesign Precision Medicine Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Oncodesign Precision Medicine (XPAR:ALOPM) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
18 rue Jean Mazen, Dijon, FRA, 21000
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine (XPAR:ALOPM) Headlines

No Headlines